Getting your player ready...
WASHINGTON — Medical experts on Tuesday voted against allowing a powerful painkiller made by Cephalon Inc. to be marketed for uses beyond treating pain in cancer patients, saying it could worsen existing misuse of the drug that has caused overdoses.
Cephalon’s drug Fentora is already approved to treat severe pain flare-ups in cancer patients already taking opioids, a type of prescription painkiller. The company wants Food and Drug Administration approval to market the drug for chronic pain not caused by cancer.
